NetworkNewsBreaks – EVIO, Inc. (EVIO) Subsidiary
Post# of 2022
EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning announced that its wholly owned Canadian subsidiary, EVIO Canada, has closed its acquisition of 50% stake in Keystone Labs Inc., a privately held Heath Canada accredited testing facility with a GMP establishment license. “We are excited to have completed this transaction and add Keystone Labs to our portfolio,” William Waldrop, CEO of EVIO, stated in the news release. “In Canada, cannabis is federally legal, however, there is a limited number of testing facilities licensed to provide services. Keystone Labs has been licensed for two years, has a strong management team, and we are confident that we can leverage our background and deployment strategies to capture significant market share.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer